Home » Topics » BioWorld Science

BioWorld Science
RSS

Araxes Pharma patents KRAS inhibitors

Aug. 22, 2018

Sun Pharma Advanced Research Co. identifies estrogen receptor antagonists

Aug. 22, 2018

UCB presents alpha-synuclein aggregation inhibitors

Aug. 22, 2018

New LRRK2 inhibitors patented by GlaxoSmithKline

Aug. 22, 2018

Sihuan initiates phase II trial with anaprazole in China

Aug. 22, 2018

At ACS national meeting, researchers share their successes

Aug. 22, 2018

Boehringer Ingelheim discovers new FFAR1 agonists

Aug. 22, 2018

Lixte partners with Moffitt for phase Ib/II study of LB-100 in low and intermediate-1 risk MDS

Aug. 22, 2018

GNE-616: a promising non-opioid drug candidate for the treatment of Nav1.7-mediated pain

Aug. 22, 2018

ProMIS Neurosciences reports positive results for PMN-310 in Alzheimer's disease

Aug. 22, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...